{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:47:32Z","timestamp":1761709652850},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2019,12,1]]},"DOI":"10.1001\/jamainternmed.2019.3107","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T16:22:34Z","timestamp":1565022154000},"page":"1712","source":"Crossref","is-referenced-by-count":10,"title":["Potential Medicare Savings From Generic Substitution and Therapeutic Interchange of ACE Inhibitors and Angiotensin-II-Receptor Blockers"],"prefix":"10.1001","volume":"179","author":[{"given":"Matthew E.","family":"Growdon","sequence":"first","affiliation":[{"name":"Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"},{"name":"Harvard Medical School Multi-Campus Geriatric Fellowship, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chana A.","family":"Sacks","sequence":"additional","affiliation":[{"name":"Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"},{"name":"Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron S.","family":"Kesselheim","sequence":"additional","affiliation":[{"name":"Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Avorn","sequence":"additional","affiliation":[{"name":"Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"8","key":"ild190032r1","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1001\/jama.2016.11237","article-title":"The high cost of prescription drugs in the United States origins and prospects for reform.","volume":"316","author":"Kesselheim","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"ild190032r2","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/jamainternmed.2016.1704","article-title":"Estimation of potential savings through therapeutic substitution.","volume":"176","author":"Johansen","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"6","key":"ild190032r4","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","article-title":"ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults.","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"12","key":"ild190032r5","first-page":"1260","article-title":"State approaches to therapeutic interchange in community pharmacy settings: legislative and regulatory authority.","volume":"24","author":"Vanderholm","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"issue":"7","key":"ild190032r6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1001\/jama.2018.11439","article-title":"Medicare spending on brand-name combination medications vs their generic constituents.","volume":"320","author":"Sacks","year":"2018","journal-title":"JAMA"},{"key":"ild190032r3","unstructured":"Centers for Medicare and Medicaid Services. Medicare Part D Drug Spending Dashboard and Data. https:\/\/www.cms.gov\/Research-Statistics-Data-and-Systems\/Statistics-Trends-and-Reports\/Information-on-Prescription-Drugs\/MedicarePartD.html. Published March 14, 2019. Accessed March 20, 2019."}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2740205\/jamainternal_growdon_2019_ld_190032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T20:07:32Z","timestamp":1575317252000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2740205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,1]]},"references-count":6,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2019.3107","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,1]]}}}